Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 1500

1.

Prescription Opioid Analgesics Increase Risk of Major Depression: New Evidence, Plausible Neurobiological Mechanisms and Management to Achieve Depression Prophylaxis.

Semenkovich K, Chockalingam R, Scherrer JF, Panagopoulos VN, Lustman PJ, Ray JM, Freedland KE, Svrakic DM.

Mo Med. 2014 Mar-Apr;111(2):148-154.

PMID:
30323529
2.

Depressive Syndromes in Autoimmune Disorders of the Nervous System: Prevalence, Etiology, and Influence.

Liu Y, Tang X.

Front Psychiatry. 2018 Sep 25;9:451. doi: 10.3389/fpsyt.2018.00451. eCollection 2018. Review.

3.

Suicide Screening and Prevention.

Bhimji SS, Dulebohn SC.

StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2018 Jan-.
2018 Sep 26.

4.

Repeat-dose ketamine augmentation for treatment-resistant depression with chronic suicidal ideation: A randomized, double blind, placebo controlled trial.

Ionescu DF, Bentley KH, Eikermann M, Taylor N, Johnson-Akeju O, Swee MB, Pavone KJ, Petrie SR, Dording C, Mischoulon D, Alpert JE, Brown EN, Baer L, Nock MK, Fava M, Cusin C.

J Affect Disord. 2019 Jan 15;243:516-524. doi: 10.1016/j.jad.2018.09.037. Epub 2018 Sep 17.

PMID:
30286416
5.

Factors mediating the impacts of child abuse and intimate partner violence on chronic pain: a cross-sectional study.

Alhalal E, Ford-Gilboe M, Wong C, AlBuhairan F.

BMC Womens Health. 2018 Oct 3;18(1):160. doi: 10.1186/s12905-018-0642-9.

6.

Propofol-Induced Masseter Muscle Spasm in a Woman with a Major Depressive Disorder.

Saeidi M, Alikhani R, Hormati A, Sabouri SM, Aminnejad R.

Anesth Pain Med. 2018 Jun 30;8(3):e78748. doi: 10.5812/aapm.78748. eCollection 2018 Jun.

7.

Milnacipran: serotonin-noradrenaline reuptake inhibitor approved for fibromyalgia may be a useful antidepressant.

Keks NA, Hope J, Keogh S, Copolov DL.

Australas Psychiatry. 2018 Oct;26(5):537-540. doi: 10.1177/1039856218794874. Epub 2018 Sep 10.

PMID:
30198305
8.

Does sickle cell disease have a psychosomatic component? A particular focus on anxiety and depression.

Toumi ML, Merzoug S, Boulassel MR.

Life Sci. 2018 Oct 1;210:96-105. doi: 10.1016/j.lfs.2018.08.066. Epub 2018 Aug 29. Review.

PMID:
30171881
9.

[Acupuncture for treatment of depressive disorders in pain diseases].

Sallach K, Leonhardt M.

Nervenarzt. 2018 Sep;89(9):986-993. doi: 10.1007/s00115-018-0576-3. Review. German.

PMID:
30076453
10.
11.

Compassion and Loving-Kindness Meditation: An Overview and Prospects for the Application in Clinical Samples.

Graser J, Stangier U.

Harv Rev Psychiatry. 2018 Jul/Aug;26(4):201-215. doi: 10.1097/HRP.0000000000000192.

PMID:
29975338
12.

Quality of life in multiple endocrine neoplasia type 2A compared with normative and disease populations.

Mongelli MN, Peipert BJ, Goswami S, Helenowski I, Yount SE, Sturgeon C.

Surgery. 2018 Sep;164(3):546-552. doi: 10.1016/j.surg.2018.04.036. Epub 2018 Jun 11.

PMID:
29903510
13.

Associations between age and the course of major depressive disorder: a 2-year longitudinal cohort study.

Schaakxs R, Comijs HC, Lamers F, Kok RM, Beekman ATF, Penninx BWJH.

Lancet Psychiatry. 2018 Jul;5(7):581-590. doi: 10.1016/S2215-0366(18)30166-4. Epub 2018 Jun 18. Erratum in: Lancet Psychiatry. 2018 Oct;5(10):e24.

PMID:
29887519
14.

The role of mirtazapine in patients with fibromyalgia: a systematic review.

Ottman AA, Warner CB, Brown JN.

Rheumatol Int. 2018 Jun 2. doi: 10.1007/s00296-018-4068-3. [Epub ahead of print] Review.

PMID:
29860538
15.

Pain catastrophizing is associated with poorer health-related quality of life in pediatric patients with sickle cell disease.

Bakshi N, Lukombo I, Belfer I, Krishnamurti L.

J Pain Res. 2018 May 8;11:947-953. doi: 10.2147/JPR.S151198. eCollection 2018.

16.

Depression and Anxiety Among Patients on Chronic Opioid Therapy.

Elrashidi MY, Philpot LM, Ramar P, Leasure WB, Ebbert JO.

Health Serv Res Manag Epidemiol. 2018 Apr 19;5:2333392818771243. doi: 10.1177/2333392818771243. eCollection 2018 Jan-Dec.

17.

Engagement in online pain self-management improves pain in adults on medication-assisted behavioral treatment for opioid use disorders.

Wilson M, Finlay M, Orr M, Barbosa-Leiker C, Sherazi N, Roberts MLA, Layton M, Roll JM.

Addict Behav. 2018 Nov;86:130-137. doi: 10.1016/j.addbeh.2018.04.019. Epub 2018 Apr 27.

PMID:
29731244
18.

[The effect of berberine on ameliorating chronic inflammatory pain and depression].

Xu F, Yang J, Meng B, Zheng JW, Liao Q, Chen JP, Chen XW.

Zhonghua Yi Xue Za Zhi. 2018 Apr 10;98(14):1103-1108. doi: 10.3760/cma.j.issn.0376-2491.2018.14.011. Chinese.

PMID:
29690724
19.

Comparative Effect of Collaborative Care, Pain Medication, and Duloxetine in the Treatment of Major Depressive Disorder and Comorbid (Sub)Chronic Pain: Results of an Exploratory Randomized, Placebo-Controlled, Multicenter Trial (CC:PAINDIP).

de Heer EW, Dekker J, Beekman ATF, van Marwijk HWJ, Holwerda TJ, Bet PM, Roth J, Timmerman L, van der Feltz-Cornelis CM.

Front Psychiatry. 2018 Apr 5;9:118. doi: 10.3389/fpsyt.2018.00118. eCollection 2018.

20.

Chronic Intra Oral Pain and Depressive Symptoms in Japanese Community-Dwelling Elderly: A Longitudinal Study.

Hanindriyo L, Yoshihara A, Takiguchi T, Miyazaki H.

Community Dent Health. 2018 May 30;35(2):102-108. doi: 10.1922/CDH_4200Hanindriyo07.

PMID:
29664579

Supplemental Content

Loading ...
Support Center